The Ebola strain now circulating has clearly undergone significant mutagenic changes in a laboratory, alterations in the nucleotide sequencing that enable it to spread more quickly and efficiently that ever before. WHO High-level meeting on Ebola vaccines access and financing (23 October 2014) – Summary Report: ‘The meeting concluded that neither affected countries nor industry should be left alone to bear the burden should lawsuits arise following possible adverse reactions to an Ebola vaccine...The principle of “pursuing all vaccines until they fail” was put forward as a wise way to maintain momentum in responding to an emergency of this scale. Representatives from industry acknowledged the investment risks they are willingly undertaking despite knowledge that a vaccine might fail or not be needed in the end.‘ ‘The recent increase in funding for Ebola vaccine research is also enabling GSK (GlaxoSmithKline) to begin manufacturing at least 10,000 additional doses of the vaccine, even as the first clinical trials are occurring.‘ Global Defence ‘Development of the vaccine candidate is progressing at an unprecedented rate, with first phase 1 safety trials with the vaccine candidate underway in the USA, UK and Mali, and further trials due to start in the coming weeks..‘ GSK update on current development status of the GSK/NIH Ebola vaccine candidate (18/10/2014) ‘GlaxoSmithKline’s monthly production capacity for purified bulk vaccine was expected to rise from the current figure of 24,000 doses to 230,000 by April 2015, if they can be filled for release. NewLink’s bulk vaccine manufacturing capacity for the Canadian vaccine was noted to vary, according to the dose selected, from 52,000 doses to 5.2 million doses anticipated for the first quarter of 2015.‘ WHO The genie is out of the bottle. Once this vaccine, and other similar concoctions, are distributed locally & internationally, the Ebola Virus protein epitope (laboratory-produced clone of Niemann-Pick C1) will spread exponentially, undergoing further mutagenic changes through viral shedding in remote communities; those otherwise completed segregated from the traditional epicentres of the outbreak. Then we will have a REAL epidemic on our hands. It is incumbent upon us, as a global community of parents & concerned individuals alike, to take action and ensure that any dire scenario of this magnitude does not manifest. As always, the paradigm shift toward self-sufficiency & self-awareness begins with you. Vaccine Resistance Movement Excerpt from VRM: Ebola Report vaccineresistancemovement.org/?p=13982
Posted on: Mon, 27 Oct 2014 14:07:22 +0000